Report Detail

Pharma & Healthcare Global Non-Invasive Cancer Diagnostics Market Professional Survey Report 2019

  • RnM3811997
  • |
  • 11 October, 2019
  • |
  • Global
  • |
  • 101 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Table of Contents

    Executive Summary

      1 Industry Overview of Non-Invasive Cancer Diagnostics

      • 1.1 Definition of Non-Invasive Cancer Diagnostics
      • 1.2 Non-Invasive Cancer Diagnostics Segment by Type
        • 1.2.1 Global Non-Invasive Cancer Diagnostics Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 CTCs
        • 1.2.3 CTNAS
        • 1.2.4 Exosomes
      • 1.3 Non-Invasive Cancer Diagnostics Segment by Applications
        • 1.3.1 Global Non-Invasive Cancer Diagnostics Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Blood
        • 1.3.3 Urine
        • 1.3.4 Saliva
      • 1.4 Global Non-Invasive Cancer Diagnostics Overall Market
        • 1.4.1 Global Non-Invasive Cancer Diagnostics Revenue (2014-2025)
        • 1.4.2 Global Non-Invasive Cancer Diagnostics Production (2014-2025)
        • 1.4.3 North America Non-Invasive Cancer Diagnostics Status and Prospect (2014-2025)
        • 1.4.4 Europe Non-Invasive Cancer Diagnostics Status and Prospect (2014-2025)
        • 1.4.5 China Non-Invasive Cancer Diagnostics Status and Prospect (2014-2025)
        • 1.4.6 Japan Non-Invasive Cancer Diagnostics Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Non-Invasive Cancer Diagnostics Status and Prospect (2014-2025)
        • 1.4.8 India Non-Invasive Cancer Diagnostics Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Non-Invasive Cancer Diagnostics
      • 2.3 Manufacturing Process Analysis of Non-Invasive Cancer Diagnostics
      • 2.4 Industry Chain Structure of Non-Invasive Cancer Diagnostics

      3 Development and Manufacturing Plants Analysis of Non-Invasive Cancer Diagnostics

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Non-Invasive Cancer Diagnostics Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Non-Invasive Cancer Diagnostics
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Non-Invasive Cancer Diagnostics Production and Capacity Analysis
      • 4.2 Non-Invasive Cancer Diagnostics Revenue Analysis
      • 4.3 Non-Invasive Cancer Diagnostics Price Analysis
      • 4.4 Market Concentration Degree

      5 Non-Invasive Cancer Diagnostics Regional Market Analysis

      • 5.1 Non-Invasive Cancer Diagnostics Production by Regions
        • 5.1.1 Global Non-Invasive Cancer Diagnostics Production by Regions
        • 5.1.2 Global Non-Invasive Cancer Diagnostics Revenue by Regions
      • 5.2 Non-Invasive Cancer Diagnostics Consumption by Regions
      • 5.3 North America Non-Invasive Cancer Diagnostics Market Analysis
        • 5.3.1 North America Non-Invasive Cancer Diagnostics Production
        • 5.3.2 North America Non-Invasive Cancer Diagnostics Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Non-Invasive Cancer Diagnostics Import and Export
      • 5.4 Europe Non-Invasive Cancer Diagnostics Market Analysis
        • 5.4.1 Europe Non-Invasive Cancer Diagnostics Production
        • 5.4.2 Europe Non-Invasive Cancer Diagnostics Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Non-Invasive Cancer Diagnostics Import and Export
      • 5.5 China Non-Invasive Cancer Diagnostics Market Analysis
        • 5.5.1 China Non-Invasive Cancer Diagnostics Production
        • 5.5.2 China Non-Invasive Cancer Diagnostics Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Non-Invasive Cancer Diagnostics Import and Export
      • 5.6 Japan Non-Invasive Cancer Diagnostics Market Analysis
        • 5.6.1 Japan Non-Invasive Cancer Diagnostics Production
        • 5.6.2 Japan Non-Invasive Cancer Diagnostics Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Non-Invasive Cancer Diagnostics Import and Export
      • 5.7 Southeast Asia Non-Invasive Cancer Diagnostics Market Analysis
        • 5.7.1 Southeast Asia Non-Invasive Cancer Diagnostics Production
        • 5.7.2 Southeast Asia Non-Invasive Cancer Diagnostics Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Non-Invasive Cancer Diagnostics Import and Export
      • 5.8 India Non-Invasive Cancer Diagnostics Market Analysis
        • 5.8.1 India Non-Invasive Cancer Diagnostics Production
        • 5.8.2 India Non-Invasive Cancer Diagnostics Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Non-Invasive Cancer Diagnostics Import and Export

      6 Non-Invasive Cancer Diagnostics Segment Market Analysis (by Type)

      • 6.1 Global Non-Invasive Cancer Diagnostics Production by Type
      • 6.2 Global Non-Invasive Cancer Diagnostics Revenue by Type
      • 6.3 Non-Invasive Cancer Diagnostics Price by Type

      7 Non-Invasive Cancer Diagnostics Segment Market Analysis (by Application)

      • 7.1 Global Non-Invasive Cancer Diagnostics Consumption by Application
      • 7.2 Global Non-Invasive Cancer Diagnostics Consumption Market Share by Application (2014-2019)

      8 Non-Invasive Cancer Diagnostics Major Manufacturers Analysis

      • 8.1 Gen-Probe Inc
        • 8.1.1 Gen-Probe Inc Non-Invasive Cancer Diagnostics Production Sites and Area Served
        • 8.1.2 Gen-Probe Inc Product Introduction, Application and Specification
        • 8.1.3 Gen-Probe Inc Non-Invasive Cancer Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Digene Corporation
        • 8.2.1 Digene Corporation Non-Invasive Cancer Diagnostics Production Sites and Area Served
        • 8.2.2 Digene Corporation Product Introduction, Application and Specification
        • 8.2.3 Digene Corporation Non-Invasive Cancer Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Quest Diagnostics Inc
        • 8.3.1 Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Production Sites and Area Served
        • 8.3.2 Quest Diagnostics Inc Product Introduction, Application and Specification
        • 8.3.3 Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Cancer, Genetics Inc
        • 8.4.1 Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Production Sites and Area Served
        • 8.4.2 Cancer, Genetics Inc Product Introduction, Application and Specification
        • 8.4.3 Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 BIOVIEW Inc
        • 8.5.1 BIOVIEW Inc Non-Invasive Cancer Diagnostics Production Sites and Area Served
        • 8.5.2 BIOVIEW Inc Product Introduction, Application and Specification
        • 8.5.3 BIOVIEW Inc Non-Invasive Cancer Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 AVIVA Biosciences Corporation
        • 8.6.1 AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Production Sites and Area Served
        • 8.6.2 AVIVA Biosciences Corporation Product Introduction, Application and Specification
        • 8.6.3 AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Laboratory Corporation of America Holdings (LabCorp)
        • 8.7.1 Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Production Sites and Area Served
        • 8.7.2 Laboratory Corporation of America Holdings (LabCorp) Product Introduction, Application and Specification
        • 8.7.3 Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 A&G Pharmaceutical
        • 8.8.1 A&G Pharmaceutical Non-Invasive Cancer Diagnostics Production Sites and Area Served
        • 8.8.2 A&G Pharmaceutical Product Introduction, Application and Specification
        • 8.8.3 A&G Pharmaceutical Non-Invasive Cancer Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Affymetrix Inc
        • 8.9.1 Affymetrix Inc Non-Invasive Cancer Diagnostics Production Sites and Area Served
        • 8.9.2 Affymetrix Inc Product Introduction, Application and Specification
        • 8.9.3 Affymetrix Inc Non-Invasive Cancer Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Precision Therapeutics
        • 8.10.1 Precision Therapeutics Non-Invasive Cancer Diagnostics Production Sites and Area Served
        • 8.10.2 Precision Therapeutics Product Introduction, Application and Specification
        • 8.10.3 Precision Therapeutics Non-Invasive Cancer Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served

      9 Development Trend of Analysis of Non-Invasive Cancer Diagnostics Market

      • 9.1 Global Non-Invasive Cancer Diagnostics Market Trend Analysis
        • 9.1.1 Global Non-Invasive Cancer Diagnostics Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Non-Invasive Cancer Diagnostics Regional Market Trend
        • 9.2.1 North America Non-Invasive Cancer Diagnostics Forecast 2019-2025
        • 9.2.2 Europe Non-Invasive Cancer Diagnostics Forecast 2019-2025
        • 9.2.3 China Non-Invasive Cancer Diagnostics Forecast 2019-2025
        • 9.2.4 Japan Non-Invasive Cancer Diagnostics Forecast 2019-2025
        • 9.2.5 Southeast Asia Non-Invasive Cancer Diagnostics Forecast 2019-2025
        • 9.2.6 India Non-Invasive Cancer Diagnostics Forecast 2019-2025
      • 9.3 Non-Invasive Cancer Diagnostics Market Trend (Product Type)
      • 9.4 Non-Invasive Cancer Diagnostics Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Non-Invasive Cancer Diagnostics Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Global non invasive cancer diagnostics and technologies market is anticipated to show lucrative growth over the forecast period owing to factor such as rising demand for minimally invasive therapeutics and diagnosis for the treatment of cancer. Moreover, increasing prevalence of cancer because of rising aging population and unhealthy lifestyle is also important factor that is fueling the growth of this market. Commercialization of non invasive cancer diagnostics and technologies is expected to grow owing to completion of human genome project (HGP) which will help in identifying chemical base pairs which make up DNA, hence opening avenues for market players. Rising awareness amongst people about the advantages of early diagnosis and treatment of cancer has led to a hike in number of people undergoing diagnosis. Furthermore, growing research and development in cancer diagnosis and treatment is another factor that is boosting the growth. Advancements in cancer detection technologies like cancer biomarkers and fluorescence in situ hybridization (FISH) technique are also expected to contribute towards the growth of this market.

        The global non invasive cancer diagnostics and technologies market is segmented into type and technology. Based on type this market is further sub segmented into breast cancer, blood cancer, lung cancer and solid tumors. Breast cancer held the largest share in 2014 owing to factor such as increasing incidence of breast cancer. Moreover, rising awareness amongst people about symptoms, diagnosis and therapies about breast cancer has contributed towards the dominance of this segment. Also, government and non-government organization’s (NGO) initiatives to create awareness about breast cancer early diagnosis and treatment are also helping to grow this market. Breast cancer segment is also expected to witness lucrative growth over the coming seven years as a consequence of advancements like lumpectomy and partial mastectomy. Based on technology the market is segmented into immunochemistry, molecular diagnosis and clinical chemistry. Molecular diagnostic market held the largest share in 2014 as a consequence of various advantages associated to it. These advantages include high precision of diagnosis such as high specificity, high sensitivity, and rapid turnaround time.

        The global Non-Invasive Cancer Diagnostics market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Non-Invasive Cancer Diagnostics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Non-Invasive Cancer Diagnostics market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Non-Invasive Cancer Diagnostics in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Non-Invasive Cancer Diagnostics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Gen-Probe Inc
        Digene Corporation
        Quest Diagnostics Inc
        Cancer, Genetics Inc
        BIOVIEW Inc
        AVIVA Biosciences Corporation
        Laboratory Corporation of America Holdings (LabCorp)
        A&G Pharmaceutical
        Affymetrix Inc
        Precision Therapeutics

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        CTCs
        CTNAS
        Exosomes

        Segment by Application
        Blood
        Urine
        Saliva


        Summary:
        Get latest Market Research Reports on Non-Invasive Cancer Diagnostics. Industry analysis & Market Report on Non-Invasive Cancer Diagnostics is a syndicated market report, published as Global Non-Invasive Cancer Diagnostics Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Non-Invasive Cancer Diagnostics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,500.00
        $5,250.00
        $7,000.00
        2,714.82
        4,072.23
        5,429.64
        3,145.23
        4,717.84
        6,290.45
        379,827.00
        569,740.50
        759,654.00
        248,056.55
        372,084.83
        496,113.10
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report